Morgan Stanley
-
-
-
-
-
-
-
The New GlaxoSmithKline (GSK) To Be Unveilied on 6/23 - Morgan Stanley
-
-
-
-
-
-
-
Drugmaker GSK to split after striking Pfizer consumer health deal
-
-
-
-
-
-
-
Reckitt, GSK balance risk-reward in high-stakes Pfizer fight
-
-
-
-
-
-
-
Gilead Sciences (GILD) Best Positioned in $22B HIV Market - Morgan Stanley
-
-
-
-
-
-
-
Pre-Open Stock Movers 4/2: (MNKD) (ENVI) (XLRN) Higher; (AGEN) (LQDT) (AGU) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Movers 8/13: (PVSW) (FMCN) (SHLD) Higher; (P) (CHK) (NPSP) Lower (more...)
-
-
-
-
-
-
-
Notable Analyst Rating Changes 02/26: RST, AZN/GSK, CHA/CHU, OSIS, LAMR Upgraded; PALM, DPS, ATHN, FLR, MOT Downgraded
-
158,450 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All